about
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingImproved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cellsTransition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.Glucose and Lipid Dysmetabolism in a Rat Model of Prediabetes Induced by a High-Sucrose Diet.Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcersCardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model.Substance P as a novel anti-obesity targetEarly cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker.Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes.Increased skin inflammation and blood vessel density in human and experimental diabetes.Mast Cells Regulate Wound Healing in DiabetesRole of neuropeptides in skin inflammation and its involvement in diabetic wound healing.Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease.Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review.Molecular and cellular mechanisms of bone morphogenetic proteins and activins in the skin: potential benefits for wound healing.Evidence of impaired adipogenesis in insulin resistance.The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers.The effect of neurotensin in human keratinocytes--implication on impaired wound healing in diabetes.Chitosan-based dressings loaded with neurotensin--an efficient strategy to improve early diabetic wound healing.Serum and renal tissue markers of nephropathy in rats under immunosuppressive therapy: cyclosporine versus sirolimus.Reply to Katlandur, Ozbek, and Keser.Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies.Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents.Study of the antidiabetic capacity of the VO(dmpp)2 complex.Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes.mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes.The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue.Neurotensin modulates the migratory and inflammatory response of macrophages under hyperglycemic conditions.Neurotensin decreases the proinflammatory status of human skin fibroblasts and increases epidermal growth factor expression.Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment.Spatial memory impairments in a prediabetic rat model.GLUT4 overexpression or deficiency in adipocytes of transgenic mice alters the composition of GLUT4 vesicles and the subcellular localization of GLUT4 and insulin-responsive aminopeptidase.Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats.Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.Elimination of glucose contamination from adipocyte glycogen extracts.Calcineurin is an important factor involved in glucose uptake in human adipocytes.Wanted: MicroRNAs to the aid of the diabetic foot
P50
Q26827627-E87344D1-D57E-4E8C-9953-7304C3A4A24BQ28743314-0265A70C-863B-4786-9F86-5285EA7C2157Q33755928-CACA29B5-9AB0-4273-8957-5020FDBE2EE3Q33852238-2886E315-1519-4288-B3F2-A29683B95EFDQ35073067-054D29BE-5487-412E-9D1C-D94B7E7B6797Q35975228-C6B3DF6C-CC32-4C3E-B626-0BF629B5A23AQ36607177-49907D26-BC48-49D5-B690-6CA412D49CC7Q36690425-B80A05D2-3ED7-442F-9732-D18793DC8528Q36775632-D2764736-2EE2-4A1B-8824-F10256C1392DQ36943958-B5E48BD3-25CE-4F03-A7CE-3E0159A7BDC0Q37025624-75E1F66C-E824-46D3-AE68-E028501923D8Q37782353-F1466895-6866-4FC8-9EE1-D2C066AD1A04Q38034934-5568D18E-5A9A-4F22-8620-3EBB2B1FF1AFQ38094490-C9FC4DCC-0D9C-4B7F-9F2E-F513CABCCAE4Q38117036-2A7485FE-2146-472F-8328-FC9CFC6319F9Q38342278-76772D31-C4F4-41A3-9DC8-D45210D60529Q38527885-5D570A88-D52E-428A-AFCF-E88AA75C5A3BQ38961364-C3BEC04E-9E45-4BD1-9A88-759491ABEC9DQ39066406-BA8BC890-D78D-4B59-87CD-C94B146808BBQ39079890-9010D599-148B-4D8D-A8A1-3610AA48F57FQ40249744-136793C8-4B43-431A-9CA7-AC238CEEF368Q40977825-33C33BEA-B59F-4017-B5A9-1B666C6082DAQ41990626-074463F8-F59D-49F7-8BB3-86676C2BF029Q42437787-277EC24A-74EE-4A70-BBA8-CD56FD04ED9AQ42461700-464FCE32-9F5E-42A9-A7ED-00C7C6207421Q42461845-B395E268-AC86-4753-8B27-6F648F1BE3F3Q42474252-2B1EBC79-1402-4579-B086-B650A0FBB33EQ42499780-281FE588-9C8C-49CB-BC3D-203CEEF38D7CQ42502113-DAEFE0C9-6365-4D8E-91F1-9E70ED84C25AQ42516160-E8EAF8B2-8FC3-4F7B-946D-A0118A8E1BC3Q42574610-CE0DF0A5-37FC-4E6E-BF0D-BE0540CE0C74Q42837357-695FF3F7-9D18-48E3-87BE-B9255AF2C69CQ44224122-D8AB46E2-AD61-43F1-A54D-765697D0807FQ44258350-6A7D90FD-498E-4ADA-A217-11A890BAABEDQ44777460-3FD6E0A5-A289-4951-9B0F-EA1752C2AE19Q45166029-93979565-BC54-45C2-8104-0ECFB8F87E60Q46520802-264D7399-65B1-4AD1-8986-10F0A751B747Q46614646-BB18CE21-1887-46FE-B1C0-B54DC8300E93Q48144855-8684508D-1940-46E1-B785-5763E4BC4CC4Q59466340-5AECAE55-5BE6-415C-8323-C1CE109A8BDA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eugénia Carvalho
@ast
Eugénia Carvalho
@en
Eugénia Carvalho
@es
Eugénia Carvalho
@nl
Eugénia Carvalho
@sl
type
label
Eugénia Carvalho
@ast
Eugénia Carvalho
@en
Eugénia Carvalho
@es
Eugénia Carvalho
@nl
Eugénia Carvalho
@sl
prefLabel
Eugénia Carvalho
@ast
Eugénia Carvalho
@en
Eugénia Carvalho
@es
Eugénia Carvalho
@nl
Eugénia Carvalho
@sl
P106
P1153
35083236900
P21
P31
P496
0000-0001-6264-3632